Literature DB >> 21801136

Inherited platelet disorders: a clinical approach to diagnosis and management.

Kelly Cox1, Victoria Price, Walter H A Kahr.   

Abstract

Inherited platelet disorders encompass a heterogeneous group of bleeding disorders where a variety of molecular defects can affect platelet number, function or both. The defects involve deficiencies or dysfunction of platelet receptors, signaling pathways, cytoskeletal proteins, granule contents and abnormalities in procoagulant activity. These disorders can be difficult to distinguish clinically as they present with the common symptom of mucocutaneous bleeding. Inherited thrombocytopenia needs to be considered in all patients suspected of having primary immune thrombocytopenia, where platelets may also have functional defects. After a careful history and physical examination, initial investigations include a complete blood count with a peripheral smear, followed by appropriate specific investigations that often require specialized referral centers. This article is a summary of the current data on clinical presentation, pathogenesis, diagnosis and management of inherited platelet disorders.

Entities:  

Mesh:

Year:  2011        PMID: 21801136     DOI: 10.1586/ehm.11.41

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


  5 in total

1.  Combined variants in factor VIII and prostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants.

Authors:  D Nance; R A Campbell; J W Rowley; J M Downie; L B Jorde; W H Kahr; S A Mereby; N D Tolley; G A Zimmerman; A S Weyrich; M T Rondina
Journal:  J Thromb Haemost       Date:  2016-10-20       Impact factor: 5.824

2.  The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis.

Authors:  Denisa Urban; Ling Li; Hilary Christensen; Fred G Pluthero; Shao Zun Chen; Michael Puhacz; Parvesh M Garg; Kiran K Lanka; James J Cummings; Helmut Kramer; James D Wasmuth; John Parkinson; Walter H A Kahr
Journal:  Blood       Date:  2012-09-21       Impact factor: 22.113

3.  Airborne particulate matters induce thrombopoiesis from megakaryocytes through regulating mitochondrial oxidative phosphorylation.

Authors:  Xiaoting Jin; Hongyan Yu; Baoqiang Wang; Zhendong Sun; Ze Zhang; Qian S Liu; Yuxin Zheng; Qunfang Zhou; Guibin Jiang
Journal:  Part Fibre Toxicol       Date:  2021-05-13       Impact factor: 9.400

4.  Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay.

Authors:  Marie Lordkipanidzé; Gillian C Lowe; Nicholas S Kirkby; Melissa V Chan; Martina H Lundberg; Neil V Morgan; Danai Bem; Shaista P Nisar; Vincenzo C Leo; Matthew L Jones; Stuart J Mundell; Martina E Daly; Andrew D Mumford; Timothy D Warner; Steve P Watson
Journal:  Blood       Date:  2014-01-09       Impact factor: 22.113

5.  Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects.

Authors:  Béatrice Hechler; Arnaud Dupuis; Pierre H Mangin; Christian Gachet
Journal:  Res Pract Thromb Haemost       Date:  2019-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.